¥3.59   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:6286.84万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:2.26亿
52周最高:8.59 52周最低:2.62 转让方式: 单位:美元
$Adverum Biotechnologies(ADVM)$
  • 还可以输入
  • 20016

Adverum Biotechnologies(ADVM) 12月04日 08时15分

新闻 Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources
MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a cli ......  url.vc.watch/nBp0
查看全文

Adverum Biotechnologies(ADVM) 12月04日 02时21分

新闻 Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy Results demonstrate single intravitreal administration of ADVM-022 ge ......  url.vc.watch/nB98
查看全文

Adverum Biotechnologies(ADVM) 11月19日 22时56分

新闻 Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration ADVM-022 is the first intravitreally delivered gene therapy util ......  url.vc.watch/nNRF
查看全文

Adverum Biotechnologies(ADVM) 11月17日 02时24分

查看全文

Adverum Biotechnologies(ADVM) 11月16日 19时04分

查看全文

Adverum Biotechnologies(ADVM) 11月14日 09时19分

新闻 Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference
MENLO PARK, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage ge ......  url.vc.watch/nqGP
查看全文

Adverum Biotechnologies(ADVM) 11月09日 17时32分

新闻 Adverum Biotechnologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update
MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasd ......  url.vc.watch/nGKK
查看全文

Adverum Biotechnologies(ADVM) 11月02日 09时15分

新闻 Adverum Biotechnologies Provides Program Updates
Preliminary data from the ADVANCE Phase 1/2 Study in A1AT deficiency showed ADVM-043 in doses of up to 1.5 x 1013 vg/kg were safely administe ......  url.vc.watch/J5cR
查看全文

Adverum Biotechnologies(ADVM) 10月25日 04时50分

查看全文

Adverum Biotechnologies(ADVM) 10月23日 04时44分

公告 Adverum Biotechnologies, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:PATTERSON LEONE D
公告日:2018-10-22, 内部交易人:PATTERSON LEONE D, 与发行人关系:President, CEO and CFO/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-10-18, SEC Accession No. 0001209191-18-055834, File:https://www.sec.gov/Archives/edgar/data/1501756/000120919118055834/0001209191-18-055834-index.htm $Adverum Biotechnologies(ADVM)$
查看全文

Adverum Biotechnologies(ADVM) 10月18日 10时15分

新闻 Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors MENLO PARK, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, ......  url.vc.watch/JKxT
查看全文

Adverum Biotechnologies(ADVM) 10月18日 05时49分

查看全文

Adverum Biotechnologies(ADVM) 10月18日 01时42分

新闻 Adverum Biotechnologies Announces Data Presented at the European Society of Gene and Cell Therapy (ESGCT) A single intravitreal injection of ADVM-022 in non-human primates (NHP) demonstrated ......  url.vc.watch/Jr1V
查看全文

Adverum Biotechnologies(ADVM) 09月20日 07时15分

新闻 Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD ADVM-022 is a unique single-administration gene therapy delivered intravitreally f ......  url.vc.watch/J94G
查看全文

Adverum Biotechnologies(ADVM) 09月19日 07时43分

新闻 Adverum to Present at Cantor Global Healthcare Conference
MENLO PARK, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy ......  url.vc.watch/JCq5
查看全文

Adverum Biotechnologies(ADVM) 09月11日 17时40分

查看全文

Adverum Biotechnologies(ADVM) 08月31日 01时16分

新闻 Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration OPTIC Phase 1 clinical trial initiation expe ......  url.vc.watch/j38w
查看全文

Adverum Biotechnologies(ADVM) 08月25日 00时27分

新闻 Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema - ADVM-053 is a novel g ......  url.vc.watch/jjtW
查看全文

Adverum Biotechnologies(ADVM) 08月16日 03时49分

新闻 Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update
MENLO PARK, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotec ......  url.vc.watch/jPVQ
查看全文

Adverum Biotechnologies(ADVM) 08月06日 22时50分

新闻 Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications Adverum Biotechnologies Appoints Katherine Bock as Vi ......  url.vc.watch/Ev2P
查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共59